首页 > 市场调查报告书 > 製药

药物开发临床实验开发业务受託机关

市场调查报告书

商品编码

1747286

临床前 CRO 市场，按服务、按类型、按动物模型、按模型系统、按应用、按最终用户、按地区

Preclinical CRO Market, By Service, By Type, By Animal Model, By Model System, By Application, By End Users, By Geography

出版日期: 2025年05月05日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球临床前 CRO 市场规模估计为 67.6 亿美元，预计到 2032 年将达到 122.1 亿美元，2025 年至 2032 年的复合年增长率为 8.82%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	67.6亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	8.82%	2032年价值预测	122.1亿美元

近年来，全球临床前 CRO 市场显着成长，这得益于製药和生技公司对外包临床前研究活动日益增长的需求。临床前合约组织 (CRO) 在药物发现和研发过程中发挥着至关重要的作用，提供广泛的服务，包括毒性测试、药物动力学和动态测试以及动物模型开发。透过简化药物开发的临床前阶段，这些组织使製药公司能够专注于其核心竞争力，并加速新治疗方法的上市。临床前 CRO 市场竞争激烈，几家主要企业在全球范围内运营，提供专业服务和先进技术，以满足客户不断变化的需求。随着製药业继续面临研发成本上升和监管审查加强等挑战，预计未来几年对临床前 CRO 服务的需求将进一步成长。

市场动态：

全球临床前CRO市场受多种因素驱动，包括製药和生物技术公司日益增加的临床前研究活动外包、对专业临床前服务的需求不断增长，以及压缩药物开发成本和时间的需求。将临床前研究委託给CRO，使公司无需投入大量资本即可获得专业知识、先进技术和最先进的设施。此外，药物开发日益复杂，以及需要遵守严格的监管要求，进一步推动了对临床前CRO服务的需求。然而，临床前研究成本高昂、熟练专家数量有限以及与资料安全和智慧财产权保护相关的挑战等因素可能会抑制市场成长。儘管有这些挑战，但由于3D细胞培养、器官晶片和In Silico模拟等先进技术的日益普及，临床前CRO市场仍显示出巨大的成长机会，这些技术有助于提高临床前研究的可预测性和效率。此外，个人化医疗需求的不断增长以及对罕见疾病和孤儿药的日益关注预计将在未来几年为临床前 CRO 创造新的商机。

本研究的主要特点

本报告对全球临床前 CRO 市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和復合年增长率。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
全球临床前 CRO 市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球临床前 CRO 市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球临床前 CRO 市场的各种策略矩阵来简化决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 6.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.82%	2032 Value Projection:	USD 12.21 Bn

The global preclinical CRO market has witnessed significant growth in recent years, driven by the increasing demand for outsourcing preclinical research activities by pharmaceutical and biotechnology companies. Preclinical Contract Research Organizations (CROs) play a crucial role in the drug discovery and development process, providing a wide range of services such as toxicology testing, pharmacokinetic and pharmacodynamic studies, and animal model development. These organizations help streamline the preclinical phase of drug development, enabling pharmaceutical companies to focus on their core competencies and accelerate the delivery of new therapies to the market. The preclinical CRO market is highly competitive, with several key players operating globally, offering specialized services and advanced technologies to meet the evolving needs of their clients. As the pharmaceutical industry continues to face challenges such as rising research and development costs and increasing regulatory scrutiny, the demand for preclinical CRO services is expected to grow further in the coming years.

Market Dynamics:

The global preclinical CRO market is driven by several factors, including the increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies, the growing demand for specialized preclinical services, and the need to reduce drug development costs and timelines. Outsourcing preclinical studies to CROs allows companies to access specialized expertise, advanced technologies, and state-of-the-art facilities, without the need for significant capital investments. Additionally, the increasing complexity of drug development, coupled with the need to comply with stringent regulatory requirements, has further fueled the demand for preclinical CRO services. However, the market growth may be restrained by factors such as the high cost of preclinical studies, the limited availability of skilled professionals, and the challenges associated with data security and intellectual property protection. Despite these challenges, the preclinical CRO market presents significant opportunities for growth, driven by the increasing adoption of advanced technologies such as 3D cell culture, organ-on-a-chip, and in silico modeling, which can help improve the predictivity and efficiency of preclinical studies. Moreover, the growing demand for personalized medicine and the increasing focus on rare diseases and orphan drugs are expected to create new opportunities for preclinical CROs in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global preclinical CRO market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global preclinical CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Charles River Laboratories, Covance (Labcorp), WuXi AppTec, ICON plc, PPD (Part of Thermo Fisher Scientific), Medpace, Evotec SE, Syneos Health, BioReliance (Merck KGaA), Charles River, KCR, Parexel International, Inotiv, Toxikon, and Harlan Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global preclinical CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical CRO market

Market Segmentation

Service Insights (Revenue, USD Bn, 2020 - 2032)
- Bioanalysis and DMPK studies
- In vitro ADME
- In-vivo PK
- Toxicology Testing
- GLP
- Non-GLP
- Compound Management
- Process R&D
- Custom Synthesis
- Others
- Chemistry
- Medicinal Chemistry
- Computation Chemistry
- Safety Pharmacology
- Others
Type Insights (Revenue, USD Bn, 2020 - 2032)
- Patient-Derived Organoid (PDO) Models
- Patient-Derived Xenograft (PDX) Models
Animal Model Insights (Revenue, USD Bn, 2020 - 2032)
- Small Animal Model
- Large Animal Model
Model System Insights (Revenue, USD Bn, 2020 - 2032)
- In Vivo
- In Vitro
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Metabolic Disorders
- Others
End Users Insights (Revenue, USD Bn, 2020 - 2032)
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
- Research Institutes and Universities
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Charles River Laboratories
- Covance (Labcorp)
- WuXi AppTec
- ICON plc
- PPD (Part of Thermo Fisher Scientific)
- Medpace
- Evotec SE
- Syneos Health
- BioReliance (Merck KGaA)
- Charles River
- KCR
- Parexel International
- Inotiv
- Toxikon
- Harlan Laboratories

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Preclinical CRO Market, By Service
- Global Preclinical CRO Market, By Type
- Global Preclinical CRO Market, By Animal Model
- Global Preclinical CRO Market, By Model System
- Global Preclinical CRO Market, By Application
- Global Preclinical CRO Market, By End Users
- Global Preclinical CRO Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Preclinical CRO Market, By Service, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Bioanalysis and DMPK studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - In vitro ADME
  - In-vivo PK
Toxicology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - GLP
  - Non-GLP
Compound Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Process R&D
  - Custom Synthesis
  - Others
Chemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Medicinal Chemistry
  - Computation Chemistry
Safety Pharmacology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Preclinical CRO Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Patient-Derived Organoid (PDO) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Patient-Derived Xenograft (PDX) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Preclinical CRO Market, By Animal Model, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Large Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Preclinical CRO Market, By Model System, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
In Vivo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
In Vitro
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Preclinical CRO Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Preclinical CRO Market, By End Users, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Government and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Institutes and Universities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Preclinical CRO Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Covance (Labcorp)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PPD (Part of Thermo Fisher Scientific)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medpace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evotec SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioReliance (Merck KGaA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Inotiv
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Toxikon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Harlan Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

临床前 CRO 市场，按服务、按类型、按动物模型、按模型系统、按应用、按最终用户、按地区